| Last updated
Hundreds of jobs will soon be up for grabs in Australia after plans for the country’s largest medical cannabis manufacturing plant were approved.
Medicinal cannabis producer LeafCann has been approved for cannabis research and medical cannabis for three years, meaning it can get to work building a $50 million start-up cultivation and processing centre.
As well as doubling the size of the existing research facility in Adelaide, it’ll be the first factory in the world to produce oil from plant genes to distribute to patients.
Construction work on the factory is expected to begin next year, creating between 200 and 800 jobs.
However, according to LeafCann co-founder and CEO Elisabetta Faenza, the location of the factory will remain confidential for ‘security’ and ‘commercial reasons’.
As per The Advertiser, Faenza said:
It is the largest manufacturing crop of any Australian licence for medicinal cannabis – so it’s a substantial manufacturing facility that has the capacity to produce many tonnes of extracted oil.
At full capacity the medicinal cannabis produced by LeafCann in South Australia will help treat 160,000 patients a year. We will be the first in the world to do this throughout the entire supply chain and SA is the headquarters of it all.
In Australia alone, the medicinal marijuana industry is expected to be worth $1 billion by 2025.
Just recently, two cannabis-based medicines used to treat epilepsy and multiple sclerosis (MS) were approved for use by the NHS.
However, facing the rigmarole of actually securing medicinal marijuana, the first major trial of the drug in the UK has launched, with 20,000 patients to test its impact on a range of conditions.
If you’re a keen smoker in the US (in a state where the drug is legalised, of course), there’s an opportunity for you to earn $36,000 a year smoking weed every day – just click here.
If you have a story you want to tell, send it to UNILAD via [email protected]
Chosen for YouChosen for You
Most Read StoriesMost Read